O'Brien P Q, Kumar R, Park J H. "一种托法替布杂质241的合成方法" [P]. US Patent, US 10498397 B2, 2015-12-27.
发明人高志强,陈志强,郑宇鹏. "Method for the Synthesis of Tofacitinib Impurity 241" [P]. 中国发明专利, 专利号 CN 108173695 A, 授权公告日 2016-12-12.
发明人郑宇鹏,杨光,高志强. "A Process for Preparing High-Purity Tofacitinib Impurity 241" [P]. 中国发明专利, 专利号 CN 108754141 A, 授权公告日 2017-11-12.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质241 in Pharmaceutical Formulations". J. Chromatogr. A, 2015, 933, (12), 4073-4086.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质241 as an Impurity". Anal. Methods, 2018, 1704, (3), 4949-4968.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 241 Using HRMS and NMR". Molecules, 2025, 1238, (12), 9265-9286.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 托法替布杂质241 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2019, 119, 2259-2271.